Ozempic (semaglutide) is a medication approved by the Food and Drug Administration (FDA) to treat type 2 diabetes
Ozempic, Wegovy and Rybelsus Linked to Vomiting Risks In a study published in the medical journal, The BMJ , on January 29, 2024, researchers identified a significant link between the use of semaglutide-based drugs, such as Ozempic and Wegovy, and an elevated risk of adverse gastrointestinal side effects , including nausea, vomiting, and diarrhea
[102] Cobalamin (vitamin B 12 ) deficiency may lead to folate deficiency, which, in turn, increases homocysteine levels and may result in the development of cardiovascular disease or birth defects
Still, access depends on meeting strict criteria and navigating prior authorization
Weight loss can normalize hormonal profiles, including increased testosterone levels in men with obesity and improved sex hormone binding globulin levels in women
GLP-1 agonists are synthetic analogues of the incretin hormone GLP-1, engineered to resist enzymatic breakdown by DPP-4 and prolong therapeutic activity
